Shanghai Fosun Pharmaceutical Owners

Health Care & Life Sciences » Pharmaceuticals | Shanghai Fosun Pharmaceutical

Shanghai Fosun Pharmaceutical | Ownership

Companies that own Shanghai Fosun Pharmaceutical

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Edinburgh Partners Ltd.

32,623,000

5.91%

-2,015,000

4.25%

07/10/2018

EARNEST Partners LLC

24,026,038

4.34%

-3,815,500

0.77%

02/20/2018

The Prudential Insurance Co. of America (Invt Port)

21,266,500

3.85%

-7,583,000

62.23%

05/31/2018

The Vanguard Group, Inc.

18,195,655

3.3%

2,227,581

07/31/2018

Wellington Management Co. LLP

16,121,713

2.92%

-88,046

0.01%

09/05/2018

Lazard Asset Management LLC

14,844,000

2.69%

0.06%

06/30/2018

Capital Research & Management Co. (International Investors)

11,812,000

2.14%

-693,500

0.05%

06/30/2018

Wellington Management Hong Kong Ltd.

11,492,222

2.08%

684,000

6.13%

09/05/2018

Capital Guardian Trust Co.

11,242,800

2.04%

72,000

0.32%

07/27/2018

BlackRock Fund Advisors

10,333,000

1.87%

09/04/2018

About Shanghai Fosun Pharmaceutical

View Profile

Address	Building A Shanghai Shanghai 200233 China
Employees	-
Website	http://www.fosunpharma.com
Updated	07/08/2019
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine.